Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China · Delayed Price · Currency is CNY 5.95
+0.06 (1.02%)
Sep 8, 2025, 2:45 PM CST
SHE:002424 Revenue
Guizhou Bailing Group Pharmaceutical had revenue of 701.39M CNY in the quarter ending June 30, 2025, a decrease of -13.42%. This brings the company's revenue in the last twelve months to 3.14B, down -30.22% year-over-year. In the year 2024, Guizhou Bailing Group Pharmaceutical had annual revenue of 3.83B, down -10.26%.
Revenue (ttm)
3.14B
Revenue Growth
-30.22%
P/S Ratio
2.59
Revenue / Employee
477.46K
Employees
6,586
Market Cap
8.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.83B | -437.59M | -10.26% |
| Dec 31, 2023 | 4.26B | 722.84M | 20.42% |
| Jan 1, 2023 | 3.54B | 429.01M | 13.79% |
| Jan 1, 2022 | 3.11B | 23.24M | 0.75% |
| Dec 31, 2020 | 3.09B | 237.30M | 8.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |